Information regarding ibuprofen in the context of COVID-19
27 March 2020
, 1 min.
In reference to the reports appearing in the media regarding the alleged impact of taking the medicinal substance ibuprofen, which belongs to the group of non-steroidal anti-inflammatory drugs (NSAIDs), on the worsening course of the disease caused by the SARS-CoV-2 virus, we inform that the European Medicines Agency states that currently there is no scientific evidence confirming the link between ibuprofen and the worsening of the COVID-19 disease course. Based on the available data, there is no reason for patients taking ibuprofen to discontinue their treatment. Such information was also published by the “Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products.”
More information can be obtained at the following addresses:
